ADVERTISEMENT

Sacubitril/valsartan may benefit patients with heart failure and diabetes

Miriam Tucker   |   Clinical Summary   |   24 June 2022
ADVERTISEMENT

Takeaway

  • Modest glucose-lowering effect of sacubitril/valsartan via reduced HbA1c and insulin initiation was similar in heart failure (HF) patients with diabetes across left ventricular ejection fraction (LVEF) spectrum.
  • Low hypoglycemia risk.

Why this matters

  • Diabetes is common in patients with HF with preserved ejection fraction.
  • Diabetes and elevated HbA1c are...

          

January Challenge

Ends in 2d 15h
left
right

Topic Challenges

left
right